Pharmabiz5m
Akums Drugs and Pharmaceuticals net profit doubles in Q2FY25
Akums Drugs and Pharmaceuticals has witnessed its net profit for the second quarter of the current fiscal year doubling to Rs. 66.65 crore from Rs. 32.69 crore registered during the same quarter last ...
Pharmabiz20m
Divis Laboratories net profit grew 47% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 11:15 Hrs [IST] Hyderabad-based Divis Laboratories has registered a growth of 46 ...
Pharmabiz35m
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...
Pharmabiz50m
Aurobindo Pharma net profit grows 8.6% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 10:45 Hrs [IST] Hyderabad-based Aurobindo Pharma has registered a growth of 8.6 ...